Platform Launches Lüt Turbo to Support Businesses with Consumer and B2B Payments

FORT LAUDERDALE, Fla.: #APIs--Lüt, a first-of-its-kind financial ecosystem built for accessibility, reliability and growth in high-risk industries, announced a strategic partnership with the American Peptide Association (APA) and American IV Association (AIVA) to deliver compliant, scalable financial infrastructure to the rapidly expanding peptide and specialty wellness sectors. As part of the collaboration, Lüt is launching Lüt Turbo, an ACH-based payments platform designed to support seamless business-to-business and consumer transactions across the industry.

The partnership comes at a pivotal moment, as the peptide and IV therapy industries continue to grow, providers continue to face persistent challenges with traditional financial institutions, including payment instability, account shutdowns and operational capital being frozen. By combining Lüt’s purpose-built payments technology with APA/AIVA’s compliance-first framework, the collaboration establishes a more reliable and transparent approach to financial services in the historically underserved, multi-billion-dollar industries.

“The partnership with APA and AIVA reflects a shared commitment to advancing more transparent solutions for the healthcare-centric financial ecosystem,” said Michael Andrud, Founder & CEO of Lüt. “Together, we are creating a system of trust for operators and patients alike that aligns with the regulatory realities of the industry while giving businesses the stability and confidence they need to grow.”

APA and AIVA, which collectively support a broad network of peptide and IV therapy providers, view the partnership as a critical step in modernizing the financial infrastructure supporting their members. By integrating Lüt’s technology, the organizations are enabling access to payments solutions that are tailored to the nuances of specialty wellness, while further professionalizing the business operations of peptide and IV therapies to match their high clinical standards.

“This partnership gives peptide and IV therapy providers something they’ve never really had: financial stability built for their world. By moving beyond one-size-fits-all payment systems to a technological infrastructure designed around their operational needs, Lüt is eliminating the constant risk of disruptions and unlocking reliable, institutional-grade processing,” said Jeff Cohen the Founder of APA and AIVA. “The result is simple-less time worrying about banking, more time focused on patient care, outcomes and scaling with confidence.”

Central to the partnership is Lüt Turbo, a newly launched ACH-based platform developed to address the limitations of legacy banking solutions. The platform supports both B2B and consumer transactions, enabling businesses to send and receive payments across multiple bank accounts, integrate directly into eCommerce environments and manage invoicing through secure payment links within a unified system. By simplifying how payments are initiated, authorized and settled, Lüt Turbo reduces operational complexity while improving speed and reliability for both merchants and their customers.

Lüt Turbo will be available to businesses nationwide with the partnership expected to drive rapid adoption across the peptide and wellness sectors. As demand for compliant, scalable payments infrastructure continues to grow, Lüt, the American Peptide Association and the American IV Association plan to expand capabilities and introduce additional innovations designed to further streamline financial operations in regulated industries.

For more information, visit mylut.com, americanpeptide.co and americaniv.com.

About Lüt®

Lüt® is more than a payment platform app-it’s a new financial ecosystem built for accessibility, reliability and growth. Lüt modernizes payments by combining traditional card processing, real-time payments, and a secure, closed-loop mobile system. Its mobile transaction model keeps pace with evolving commerce, from online retail to emerging sectors like cannabis, peptides and iGaming. Built on the first proprietary payment rails created since 1986 and supported through a strategic partnership with First Federal Bank of Florida (FFB), Lüt delivers faster settlements, cash-back incentives for users and transparent pricing without relying on outdated intermediaries. Lüt's leadership team brings decades of experience in the fintech space to streamline the payment process for merchants and consumers alike with easy to use emerging real-time payments technology. Learn more at mylut.com.

About the American Peptide Association

The American Peptide Association (APA) is a professional body committed to the clinical integrity and continued availability of peptide therapies. The APA prioritizes the collection of observational cohort data and real-world evidence to help document the efficacy and safety of peptide treatments as well as establish quality. The association serves as a primary advocate for clinical transparency and evidence-based standards, bridging the gap between innovative wellness therapies and institutional healthcare requirements.

About the American IV Association

The American IV Association (AIVA) is the leading professional organization dedicated to the safety, ethics, and business sustainability of the intravenous hydration and wellness industry. AIVA provides its members with a comprehensive suite of resources, including clinical guidelines, legal templates, compliance frameworks, and operational strategies. By fostering a culture of excellence and clinical-first protocols, AIVA ensures that providers can deliver high-quality care while navigating a complex regulatory landscape.

Fonte: Business Wire